Sodium Nitroprusside: The Forgotten Vasodilator? A Brief Guide for Informed and Safe Use from Heart Failure to Hypertensive Crisis and Aortic Dissection

Sodium nitroprusside (SNP) is a powerful vasodilator approved for treating acute hypertensive crises, acute heart failure, aortic dissection, and both controlled perioperative hypotension and perioperative hypertension. Its unique ability to cause both venous and arterial dilation makes it an invaluable option in critical care settings. Despite concerns regarding its manageability due to potential toxicity, it is a safe choice if properly used, as highlighted by its short half-life and minimal side effects. This review aims to summarize its pharmacological properties, toxicology, and various clinical applications, particularly focusing on acute heart failure and hypertensive emergencies.

Authors

Institutions

Publication Details

Journal
Future Pharmacology
Published
2024-12-26
DOI
https://doi.org/10.3390/futurepharmacol5010001
Citations
4
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sodium Nitroprusside: The Forgotten Vasodilator? A Brief Guide for Informed and Safe Use from Heart Failure to Hypertensive Crisis and Aortic Dissection

Rosa Franzese, Saverio D’Elia, Paolo Golino, Carmine Gentile et al.
4 citations
Future Pharmacology
Heart Failure Treatment and Management
1.61
article

Sodium Nitroprusside: The Forgotten Vasodilator? A Brief Guide for Informed and Safe Use from Heart Failure to Hypertensive Crisis and Aortic Dissection

Rosa Franzese, Saverio D’Elia, Paolo Golino, Carmine Gentile, Francesco Natale, Antonio Caiazzo, Giovanni Cimmino, Francesco S. Loffredo, Ettore Luisi, Achille Solimene
article en
4 citations

Abstract

Sodium nitroprusside (SNP) is a powerful vasodilator approved for treating acute hypertensive crises, acute heart failure, aortic dissection, and both controlled perioperative hypotension and perioperative hypertension. Its unique ability to cause both venous and arterial dilation makes it an invaluable option in critical care settings. Despite concerns regarding its manageability due to potential toxicity, it is a safe choice if properly used, as highlighted by its short half-life and minimal side effects. This review aims to summarize its pharmacological properties, toxicology, and various clinical applications, particularly focusing on acute heart failure and hypertensive emergencies.

Future PharmacologyVol. 5(1)
University of Campania "Luigi Vanvitelli" (IT), Ospedale Monaldi (IT), Link Campus University (IT)
Good health and well-being
Openalex Percentile: Top 14%
Heart Failure Treatment and Management
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sodium Nitroprusside: The Forgotten Vasodilator? A Brief Guide for Informed and Safe Use from Heart Failure to Hypertensive Crisis and Aortic Dissection — Rosa Franzese, Saverio D’Elia, et al. · Future Pharmacology (2024) | TGRS Research Map | TGRS